1. Home
  2. TECX vs BRDG Comparison

TECX vs BRDG Comparison

Compare TECX & BRDG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TECX
  • BRDG
  • Stock Information
  • Founded
  • TECX 2019
  • BRDG 2009
  • Country
  • TECX United States
  • BRDG United States
  • Employees
  • TECX N/A
  • BRDG N/A
  • Industry
  • TECX
  • BRDG Investment Managers
  • Sector
  • TECX
  • BRDG Finance
  • Exchange
  • TECX Nasdaq
  • BRDG Nasdaq
  • Market Cap
  • TECX 334.4M
  • BRDG 391.6M
  • IPO Year
  • TECX 2018
  • BRDG 2021
  • Fundamental
  • Price
  • TECX $21.51
  • BRDG $9.20
  • Analyst Decision
  • TECX Buy
  • BRDG Hold
  • Analyst Count
  • TECX 6
  • BRDG 5
  • Target Price
  • TECX $79.20
  • BRDG $11.30
  • AVG Volume (30 Days)
  • TECX 172.8K
  • BRDG 296.8K
  • Earning Date
  • TECX 05-08-2025
  • BRDG 06-10-2025
  • Dividend Yield
  • TECX N/A
  • BRDG 5.00%
  • EPS Growth
  • TECX N/A
  • BRDG N/A
  • EPS
  • TECX N/A
  • BRDG N/A
  • Revenue
  • TECX N/A
  • BRDG $453,729,000.00
  • Revenue This Year
  • TECX N/A
  • BRDG N/A
  • Revenue Next Year
  • TECX N/A
  • BRDG $36.21
  • P/E Ratio
  • TECX N/A
  • BRDG N/A
  • Revenue Growth
  • TECX N/A
  • BRDG 39.05
  • 52 Week Low
  • TECX $13.70
  • BRDG $6.81
  • 52 Week High
  • TECX $61.07
  • BRDG $11.69
  • Technical
  • Relative Strength Index (RSI)
  • TECX 51.42
  • BRDG 43.92
  • Support Level
  • TECX $21.20
  • BRDG $8.96
  • Resistance Level
  • TECX $22.75
  • BRDG $9.46
  • Average True Range (ATR)
  • TECX 1.43
  • BRDG 0.21
  • MACD
  • TECX 0.01
  • BRDG -0.09
  • Stochastic Oscillator
  • TECX 41.32
  • BRDG 15.41

About TECX Tectonic Therapeutic Inc. Common Stock

Tectonic Therapeutic Inc is a biotechnology company focused on the discovery and development of therapeutic proteins and antibodies that modulate the activity of GPCRs. Its technology platform called GEODe, Tectonic is focused on developing biologic medicines that overcome the existing challenges of GPCR-targeted drug discovery to modify the course of disease. Company focus on areas of important unmet medical need, often where therapeutic options are poor or nonexistent, and where new medicines have the potential to improve patient quality of life or extend duration of life. Pipeline includes TX000045, Group 2 PH, TX2100: GPCR Antagonist for Hereditary Hemorrhagic Telangiectasia (HHT), Fibrosis.

About BRDG Bridge Investment Group Holdings Inc.

Bridge Investment Group Holdings Inc is a vertically integrated investment manager, diversified across specialized asset classes. The company combines its operating platform with dedicated teams of investment professionals focused on various specialized and synergistic investment platforms, including real estate, credit, renewable energy, and secondaries strategies. Its products and vertically integrated structure allow it to capture new market opportunities and serve investors with various investment objectives. The Company operates as one business, a fully integrated real estate investment manager.

Share on Social Networks: